We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- COVID-19 (81)
- Advertising (66)
- Labelling and packaging (10)
- Vaping hub (8)
- Legislation (7)
- Safety monitoring and information (4)
- Compliance and enforcement (3)
- Manufacturing (3)
- Medicinal cannabis hub (3)
- Scheduling (national classification system) (2)
- Committees and advisory bodies (1)
- Import and export (1)
- Shortages and supply disruptions (1)
- Sunscreens (1)
- Weight loss products (1)
Search
217 result(s) found, displaying 126 to 150
-
Media releasesThe TGA has issued one infringement notice of $2,664 to a Sydney based individual for alleged unlawful importation of unregistered anaesthetic products.
-
Media releasesThe TGA has determined that the BBIBP-CorV (Sinopharm) COVID-19 vaccine will be 'recognised' for all ages for the purpose of establishing a traveller's vaccination status when entering Australia.
-
Media releasesThe TGA has received and commenced evaluation of an application to extend the use of its COVID-19 vaccine, SPIKEVAX, to children aged 6 months to 5 years old.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
News articlesThe Prescribing Medicines in Pregnancy database has now been updated.
-
Media releasesFuturePro was convicted and released on recognisance, its directior was convicted and fined $25,000.
-
News articlesOn 10 July 2020 the Therapeutic Goods Administration (TGA) granted provisional approval to remdesivir ("Veklury", Gilead Sciences Pty Ltd) as the first treatment option for COVID-19
-
News articlesOn 20 August 2021 the TGA granted provisional approval to GlaxoSmithKline Australia Pty Ltd in relation to sotrovimab (XEVUDY).
-
Media releasesIndividual fined $2,664 for unlawful importation of nicotine vaping pods
-
Media releasesOn 7 April 2022, the TGA announced receipt of an application from GlaxoSmithKline (GSK) Australia Pty Ltd for a higher (1000 mg) dose of its COVID-19 treatment, XEVUDY (sotrovimab).
-
Media releasesThe TGA has granted provisional approval to Gilead Sciences Pty Ltd to extend the use of the COVID-19 treatment, VEKLURY (remdesivir).
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Regulatory decision noticesThe TGA has provisionally approved the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for use as a booster in individuals aged 12 to 15 years old.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesOn 27 April 2022 the TGA granted a provisional determination to Moderna Australia Pty Ltd in relation to its bivalent COVID-19 vaccine, elasomeran/elasomeran 0-omicron (SPIKEVAX Bivalent Zero/Omicron).
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Safety updatesMedicines Safety Update - Information for health professionals
-
News articlesThe TGA has now approved an application from the sponsor for an extension of shelf-life to 18 months when stored at 2°C to 8°C.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesCheckMe Pty Ltd fined $13,320 for unlawful import of COVID-19 test kits
-
Media releasesG1 Resources Pty Ltd fined for alleged unlawful importation and advertising of unapproved rapid antigen tests
-
Media releasesCat Media Pty Ltd fined $39,960 for allegedly advertising unregistered Fatblaster weight-loss products
-
Media releasesDentist fined $5,328 for alleged unlawful importation of botox
-
Media releasesThe TGA has provisionally approved the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for use as a booster in individuals aged 12 to 15 years old.